Meeting
2024 ASCO Genitourinary Cancers Symposium
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immunotherapy: A systematic review and meta-analysis.
Authors
Fengnian Zhao
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China
Fengnian Zhao , Junru Chen , Haoyang Liu , Hao Zeng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 427)
DOI
10.1200/JCO.2024.42.4_suppl.427
Abstract #
427
Poster Bd #
H9
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma.
First Author: Ciara Conduit
Poster
2022 ASCO Annual Meeting
The effect of the microbiome on immune checkpoint inhibitor toxicity in patients with melanoma.
First Author: Nyelia Williams
Poster
2022 ASCO Annual Meeting
A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma.
First Author: Sophia Z. Shalhout
Poster
2021 ASCO Annual Meeting
Impact of BRAF mutations on prognosis and immunotherapy response in microsatellite instability/mismatch repair deficient metastatic colorectal cancer: A systematic review and meta-analysis.
First Author: Robin Park